Connect with us
European Gaming Congress 2024

Artificial Intelligence

Caristo Diagnostics Offers £500 to First 100 UK Patients Who Get Advanced Heart Health Screening

Published

on

caristo-diagnostics-offers-500-to-first-100-uk-patients-who-get-advanced-heart-health-screening

OXFORD, England, Sept. 25, 2024 /PRNewswire/ — In recognition of World Heart Day on Sept. 29, Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has launched a UK-wide campaign to encourage annual heart-health checks. Caristo will pay £500 to the first 100 people who undergo a physician-approved cardiac CT scan and have it analysed by Caristo’s CaRi-Heart® technology between Sept. 29 and Oct. 15, 2024.

CaRi-Heart® technology is the only solution in the world able to accurately predict cardiac events up to 10 years in advance by quantifying previously invisible coronary artery inflammation. The technology applies advanced AI algorithms to routine coronary tomography angiography (CCTA) heart scans to visualise and quantify coronary inflammation, a key driver of coronary artery disease and fatal heart attacks.
A May 29 study in the medical journal, The Lancet, examined CaRi-Heart analysis of 40,000 CCTA heart scans and confirmed that the technology can detect invisible coronary inflammation and determine an individual’s long-term risk of a fatal cardiac event. CaRi-Heart’s unique ability to see coronary inflammation is crucial for the significant number of patients with chest pain who receive a negative CCTA result but nevertheless remain at high risk for cardiovascular events.
Campaign Rules
To qualify for the £500 cash rebate, patients must undergo a cardiac CT (CCTA) scan and CaRi-Heart analysis, which will be billed as usual by their physician. The £500 rebates will be provided directly to patients after both services have been completed. Participants should first speak with their consulting physician to understand if a CaRi-Heart analysis is recommended for them.
See Caristo’s website page here, for further details on the campaign and a list of participating clinics.
“At Caristo, prevention of coronary artery disease is the heart of our mission, and we take pride in bringing the revolutionary CaRi-Heart technology to patients,” said Frank Cheng, CEO of Caristo. “Our hope is that this campaign will inspire more people to prioritise annual heart screenings and take proactive steps toward managing their health”
Help Decide British Heart Foundation Award Winner
Amid continuing focus on innovative treatments for heart disease, the British Heart Foundation is inviting the public to vote for the winner of the 2024 BHF Research Project of the Year recognising researchers and projects that have helped advance the BHF’s mission to fund life-saving research.
One of the three finalists for the award is Charalambos Antoniades, MD, the British Heart Foundation Professor of Cardiology Medicine at the University of Oxford, whose research led directly to the development of CaRi-Heart® technology.
Those interested in learning more about Prof. Antoniades’ work and that of the other award finalists can visit https://www.bhf.org.uk/how-you-can-help/bhf-research-story-of-the-year to cast their vote for the BHF Research Project of the Year winner.
About Caristo Diagnostics
Caristo Diagnostics is a global leader in cardiac and vascular disease diagnostics and risk prediction. Founded in 2018 as a spin-out company from the University of Oxford, the world’s #1 research university, Caristo has developed a portfolio of imaging-based and AI-assisted platforms that can be applied to aid the prediction and diagnosis of heart attack, stroke, and diabetes. Caristo has been recognized by Newsweek as one of the best digital health companies, and highlighted by Nature as one of the most exciting science-based companies to have emerged from academic labs. Find Caristo online on its website, LinkedIn and X.
Logo – https://mma.prnewswire.com/media/2054669/Caristo_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/caristo-diagnostics-offers-500-to-first-100-uk-patients-who-get-advanced-heart-health-screening-302257705.html

Continue Reading
Advertisement

Artificial Intelligence

Firstsource positioned as a ‘Leader’ in Lending Services Operations PEAK Matrix® Assessment 2024 by Everest Group

Published

on

firstsource-positioned-as-a-‘leader’-in-lending-services-operations-peak-matrix-assessment-2024-by-everest-group

MUMBAI, India, Sept. 27, 2024 /PRNewswire/ — Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), a leading global provider of specialist domain-led Business Process Services (BPS) and an RP-Sanjiv Goenka Group company, has been positioned as a Leader in the Everest Group’s Lending Services Operations PEAK Matrix® Assessment 2024.

The Lending Services Operations PEAK Matrix ® Assessment 2024 evaluated and classified 30 lending service providers based on their market impact, and vision, and capability, as well as scalability and client references into the three categories of Leaders, Major Contenders, and Aspirants. Firstsource was positioned as a ‘Leader’ among service providers for achieving growth, despite challenging market conditions, offering a balanced range of services across the lending value chain—commercial, consumer, mortgage, and auto lending – providing a diverse set of clients with a complete experience, driving innovation, and investing to augment their Al-based in-house solutions suite.
Vivek Sharma, President – BFS, CMT, and Emerging Geos, Firstsource, shared, “Being recognized as a Leader in the 2024 Lending Services Operations PEAK Matrix® Assessment is a powerful validation of our focused strategy. We have deliberately chosen to limit our domains and deepen our expertise in those areas, and this recognition reinforces that commitment. Our comprehensive operations, supported by Collection and Lending Innovation Labs in the U.S. and U.K., leverage AI-driven solutions and a strategic global reach to enhance customer experience, drive operational excellence, and deliver innovation—all under one roof.
“As the lending services industry continues to evolve, our emphasis on innovation and value creation across the entire lending value chain positions us as a trusted partner for organizations seeking to future-proof their business. This acknowledgment highlights our role in driving the future of the industry and solidifies our leadership in delivering cutting-edge solutions that meet the complex needs of our clients.”
Sahil Chaudhary, Practice Director, Everest Group, shared, “Firstsource’s impetus on innovation and digital solutions has helped it to drive growth, as well as making it a preferred BPS partner amid the challenging economic landscape in the lending operations market. Their well-diversified clientele across the lending value chain, combined with strategic investments in in-house AI-based solutions, has established it as a Leader in Everest Group’s Lending Services Operations PEAK Matrix® Assessment 2024.”
To download a copy of the assessment, please visit: Firstsource Named a Global Leader by Everest Group Peak Matrix 2024 – Firstsource
About Firstsource
Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL) (BSE: 532809) (Reuters: FISO.BO) (Bloomberg: FSOL:IN), is a specialized global business process services partner, providing transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, and other diverse industries. With an established presence in the US, the UK, India, Mexico, Australia, South Africa, and the Philippines, we make it happen for our clients, solving their biggest challenges with hyper-focused, domain-centered teams and cutting-edge tech, data, and analytics. Our real-world practitioners work collaboratively to deliver future-focused outcomes. (www.firstsource.com)
Photo: https://mma.prnewswire.com/media/2515459/Firstsource_PEAK_Matrix.jpgLogo: https://mma.prnewswire.com/media/2515360/Firstsource_Logo.jpg
 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/firstsource-positioned-as-a-leader-in-lending-services-operations-peak-matrix-assessment-2024-by-everest-group-302260029.html

Continue Reading

Artificial Intelligence

Frost & Sullivan Awards MC Digital Realty 2024 Japan Company of the Year Award for Leading Data Center Solutions

Published

on

frost-&-sullivan-awards-mc-digital-realty-2024-japan-company-of-the-year-award-for-leading-data-center-solutions

MC Digital Realty leverages advanced technology and strategic investments to provide comprehensive colocation services in Japan’s data center market, addressing Japanese businesses’ needs for sustainability and AI workloads
SAN ANTONIO, Sept. 27, 2024 /PRNewswire/ — Frost & Sullivan recently researched the data center services industry and, based on its findings, recognizes MC Digital Realty: A Mitsubishi Corporation and Digital Realty Company, with the 2024 Japan Data Center Services Company of the Year Award. MC Digital Realty offers a full spectrum of data center solutions to over 5,000 customers across more than 25 countries on six continents.

“The company demonstrates a strong focus on the Japanese market through continued investments. Strategic partnerships and innovations aligning with transforming customer expectations enable the service provider to achieve success in the country,” said Nishchal Khorana, Global Vice President of ICT at Frost & Sullivan.
The company’s state-of-the-art data centers are designed to meet the rigorous demands of AI workloads, providing flexible and customized facilities that can easily handle intensive model training and real-time inferencing. By leveraging the strength of PlatformDIGITAL® Digital Realty’s global data center platform, MC Digital Realty interconnects over 1,100 cloud and IT services, 1,200 network services in 25+ countries, 50+ metros, and 300+ data center locations on six continents. Additionally, MC Digital Realty’s investments in liquid cooling solutions have enabled multiple data centers to handle the high-density demands of AI applications, solidifying the company’s position as a market leader.
The company regularly optimizes its operational resilience and disaster preparedness. It strategically locates its data centers in areas with low seismic risk and employs innovative seismic isolation technology to protect its infrastructure from natural disasters. Moreover, its commitment to turning data into actionable insights ensure uninterrupted customer service and unsurpassed reliability, helping the company stay at the top of its industry.
MC Digital Realty also demonstrates its market leadership by leveraging its relationship with Mitsubishi Corporation to match electricity usage in its colocation data halls with 100% carbon-free and renewable energy. It integrates advanced cooling technologies and energy-efficient infrastructure to minimize its carbon footprint. By adopting these green practices, the company meets ever-evolving regulatory requirements and exceeds industry standards, setting a new benchmark for environmental responsibility in the market. This initiative aligns with the growing demand for sustainable practices and reflects the company’s dedication to reducing its environmental impact.
“MC Digital Realty matches the electricity usage in the colocation service data hall at its NRT10 and KIX11 data centers with 100% carbon-free and renewable energy by purchasing FIT non-fossil certificates from MC Retail Energy. This commitment to renewable energy demonstrates sustainability prioritization and aligns with the growing demand for sustainable practices among customers,” said Ojaswi Rana, Best Practices Research Analyst at Frost & Sullivan.
“We are deeply honored to receive this award from Frost & Sullivan, a testament to our unwavering dedication to innovation and setting standards of excellence in the dynamic data center industry. Leveraging the strength of PlatformDIGITAL™, MC Digital Realty empowers businesses to harness the full potential of AI by delivering cutting-edge, sustainable facilities that anticipate future demands. This recognition validates our commitment to providing unparalleled flexibility, reliability, and environmental stewardship as we catalyze our clients’ accelerated digital transformation,” said Kosei Hatakeyama, Representative Director and CEO, MC Digital Realty, in accepting the award. 
Each year, Frost & Sullivan presents a Company of the Year Award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Frost & Sullivan Best Practices Awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Contact:
Tarini SinghP: +91- 9953764546E: [email protected] 
About MC Digital Realty
MC Digital Realty, Inc., established in September 2017, is a 50/50 joint venture between Mitsubishi Corporation and Digital Realty. The company provides the full spectrum of data center services in Japan, including colocation and interconnection solutions, by leveraging MC’s real estate and infrastructure investment expertise and customer network, as well as Digital Realty’s leading global data center platform, PlatformDIGITAL®, with 5,000+ customers across 300+ data centers on six continents. For more information about MC Digital Realty, please visit https://www.mc-digitalrealty.com/ or follow us on LinkedIn.
Contact:
MC Digital Realty Public Relations OfficeE: [email protected]
About Digital Realty
Digital Realty brings companies and data together by delivering the full spectrum of data center, colocation and interconnection solutions. PlatformDIGITAL®, the company’s global data center platform, provides customers with a secure data meeting place and a proven Pervasive Datacenter Architecture (PDx®) solution methodology for powering innovation and efficiently managing Data Gravity challenges. Digital Realty gives its customers access to the connected data communities that matter to them with a global data center footprint of 300+ facilities in 50+ metros across 25+ countries on six continents. To learn more about Digital Realty, please visit digitalrealty.com or follow us on LinkedIn and X.
Contact:
Sin Huay HoP: +65 8125 8380E: [email protected]
Photo – https://mma.prnewswire.com/media/2516459/MC_Digital_Award.jpg

View original content:https://www.prnewswire.co.uk/news-releases/frost–sullivan-awards-mc-digital-realty-2024-japan-company-of-the-year-award-for-leading-data-center-solutions-302259947.html

Continue Reading

Artificial Intelligence

AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through 2029

Published

on

ai-in-life-sciences-market-poised-for-explosive-growth-with-27.9%-cagr-through-2029

AI Revolutionizes Life Sciences: Transforming Drug Discovery, Personalized Medicine, and Patient Outcome. BCC Research Study Projects a 27.9% CAGR, with Market Growth from $9.8 Billion in 2024 to $33.5 Billion by 2029
BOSTON, Sept. 26, 2024 /PRNewswire/ — “According to the latest BCC Research study, the demand for “Artificial Intelligence (AI) in Life Sciences Market” is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.”

The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences, highlighting key trends and regional dynamics that are shaping the future of this transformative field.
This report is particularly relevant at this moment due to the rapid advancements and accelerating adoption of artificial intelligence within the life sciences industry. As the volume and complexity of biological data continue to increase, there is a pressing need for innovative technologies that can enhance our ability to understand, diagnose, and treat various diseases. AI is at the forefront of these advancements, offering transformative potential to revolutionize healthcare by enabling more precise and efficient solutions. The global COVID-19 pandemic has further emphasized the importance of AI, highlighting its critical role in speeding up drug discovery, developing vaccines, and improving diagnostic tools. With these unprecedented challenges and opportunities, this report provides essential insights into the current state and future impact of AI in life sciences, making it a valuable resource for stakeholders seeking to navigate and capitalize on this rapidly evolving field.
Please click here for more details on “The global market for artificial intelligence (AI) in life sciences products Report.”
The following factors drive the global market for artificial intelligence (AI) in life sciences products:
Increasing Adoption of AI-Driven Solutions for Drug Discovery and Development: AI is transforming the drug discovery and development landscape by drastically cutting down the time and costs traditionally associated with these processes. Where conventional methods might take years and billions of dollars, AI can swiftly analyze large datasets to pinpoint potential drug candidates and forecast their efficacy and safety. This accelerates the preliminary stages of drug discovery, enabling researchers to concentrate on the most promising compounds. Moreover, AI aids in refining clinical trial designs, identifying appropriate patient groups, and predicting trial outcomes, further expediting the development pipeline.
Rising Need for Precision Medicine and Personalized Treatment Approaches: Precision medicine focuses on tailoring medical treatments to the unique characteristics of each patient. AI is instrumental in this process by analyzing genetic, environmental, and lifestyle factors to determine the most effective treatment strategies for individual patients. This personalized approach leads to improved patient outcomes, as therapies are specifically crafted to address the distinct aspects of a patient’s condition. Additionally, AI allows for real-time monitoring of patient responses, enabling rapid adjustments to treatment plans when needed. This level of customization is becoming increasingly vital as healthcare shifts towards more patient-centered models.
Request a sample copy of the global market for artificial intelligence (AI) in life sciences products report:
Report Synopsis
Report Metrics
Details
Base year considered
2023
Forecast Period considered
2024-2029
Base year market size
$8.0 billion
Market Size Forecast
$33.5 billion
Growth rate
CAGR of 27.9% from 2024 to 2029
Segment Covered
By Product Segment, Application, End User, and Region
Regions covered
North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Key Market Drivers
•  Increasing adoption of AI-driven solutions for drug discovery and development
•  Rising need for precision medicine and personalized treatment approaches
 
Key Interesting Facts About the global market for artificial intelligence (AI) in life sciences products:
1.  AI in Drug Discovery and Development:
AI accelerates drug discovery by rapidly screening millions of compounds.It generates novel drug candidates, transforming drug development.Virtual clinical trials streamline research, reducing costs.2.  AI in Precision Medicine and Medical Imaging:
Precision medicine tailors treatments based on genetic analysis.AI excels in medical imaging analysis, aiding diagnoses.Machine learning detects subtle patterns, aiding early disease detection.The global market for artificial intelligence (AI) in life sciences products report includes in-depth data and analysis addressing the following important queries:
1.  What is the projected market size and growth rate of Artificial Intelligence (AI) in the Life Sciences market?
The global Artificial Intelligence (AI) In Life Sciences market was valued at $8.0 billion in 2023 and is expected to reach $33.5 billion by the end of 2029, expected to grow at a CAGR of 27.9% from 2024 to 2029.2.  What are the key factors driving the growth of artificial intelligence (AI) in the life sciences market?
The growth of Artificial Intelligence (AI) in the Life Sciences market is primarily driven by the increasing adoption of AI-driven solutions for drug discovery and development, the rising need for precision medicine and personalized treatment approaches, and the demand for advanced diagnostic tools to analyze complex biological data.3.  What segments are covered in the global Artificial Intelligence (AI) in the Life Sciences market?
The global Artificial Intelligence (AI) market in the Life Sciences is segmented based on product, application, end-user, and region.4.  By Type, which segment will dominate the market by the end of 2029?
The software segment will dominate the market by the end of 2029.5.  Which region has the highest market share in Artificial Intelligence (AI) in the Life Sciences market?
North America holds the highest share of the market. Some of the Key Market Players Are:
AICUREAPIXIOATOMWISE INC.BENEVOLENTAIENLITIC INC.NUMEDII INC.RECURSIONZEBRA TECHNOLOGIES CORP.Browse Related Reports:
Global Markets for Artificial Intelligence in Drug Discovery: This report provides a comprehensive overview of AI in the drug discovery market, analyzing trends from 2020, recent estimates from 2021, and projecting compound annual growth rates through 2028. It focuses on market dynamics such as regulatory scenarios, drivers, restraints, and opportunities, highlighting the potential across applications including preclinical testing, target identification, candidate screening, lead optimization, drug repurposing, and De novo drug design. Therapeutic areas covered include oncology, neurodegenerative diseases, cardiovascular diseases, metabolic diseases, and infectious diseases. Regional analysis spans North America, Europe, Asia-Pacific, and the Rest of the World, with detailed insights into key countries like the U.S., Germany, the U.K., Italy, France, Japan, China, and India.
Directly purchase a copy of the report with BCC Research.
For further information or to make a purchase, please get in touch with [email protected]
About BCC Research
BCC Research provides objective, unbiased measurement, and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.
Contact UsCorporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USAEmail: [email protected],Phone: +1 781-489-7301
For media inquiries, email [email protected] or visit our media page for access to our market research library.
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo – https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ai-in-life-sciences-market-poised-for-explosive-growth-with-27-9-cagr-through-2029–302260398.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending